- Lewis Chodosh, University of Pennsylvania
Nanoparticles which combine magnetic hyperthermia and anti-cancer drug delivery show potential as a new treatment to target and kill breast cancer cells.
Carol Fabian et al. review early investigations into the use of omega-3 supplementation to prevent breast cancer and to improve outcomes following breast cancer diagnosis.
Adipose cells in the tumour microenvironment may be contributing to resistance to Trastuzumab, a targeted treatment for HER2+ breast cancer.
Long non-coding RNA profiles were found to predict risk of metastases in lymph node-negative breast cancer patients, and hence may be a source of prognostic information used to combat overtreatment.
Despite concerns to the contrary, a large study of women in France finds that exposure to dioxins through dietary intake is not associated with an increased risk of breast cancer.
A combination of virtual screening and biochemical assays identified new small-molecule estrogen receptor inhibitors with the potential for use in novel endocrine-based therapies.
From the blog
Aims & scope
Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.
- 18 May 2015
- Cancer survivors have evolving information needs